Clinical Trials Sponsored by LIVMOR, Inc.

Total 35866 results

Lavior Pharma Inc.

Recruiting

Restoring Tissue and Evaluating Novel Treatments for Efficacy in Wounds (RENEW)

Diabetic Foot Ulcer

United States
Livzon Pharmaceutical Group Inc.

Completed

A Multi-center, Double-blinding, Parallel and Positive-controlled Phase III Clinical Trial for Efficacy and Safety Evaluation of Ilaprazole Sodium for Injection on Prevention of Stress Ulcer Bleeding

Stress Ulcer Bleeding

China
Livzon Pharmaceutical Group Inc.

Active, not recruiting

A Preliminary Exploratory Study to Evaluate the Safety and Immunogenicity of Omicron Variant Bivalent Vaccine V-01-B5 (COVID-19)

COVID-19 Pandemic

China
Livzon Pharmaceutical Group Inc.

Active, not recruiting

The Immunogenicity and Safety of V-01-351/V-01D Bivalence Vaccine (Omicron)

COVID-19 Pandemic

China
Livzon Pharmaceutical Group Inc.

Active, not recruiting

Recombinant SARS-CoV-2 Fusion Protein Vaccine Booster Immunization Study to Evaluate the Safety and Immunogencity (COVID-19)

COVID-19 Pandemic

China
Livzon Pharmaceutical Group Inc.

Active, not recruiting

Clinical Study for Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) Booster Immunization (COVID-19)

COVID-19 Pandemic

China
Livzon Pharmaceutical Group Inc.

Completed

LZM009 to Treat Patients With Advanced Solid Tumors

Solid Tumor

United States
Livzon Pharmaceutical Group Inc.

Unknown

Clinical Research on Effectiveness and Safety of Treatment of Severe Oligospermia or Azoospermia With uFSH

Azoospermia | Oligospermia

China
Livzon Pharmaceutical Group Inc.

Unknown

Ilaprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Chinese Patients

Gastroesophageal Reflux Disease
Livzon Pharmaceutical Group Inc.

Completed

Ilaprazole for the Treatment of Duodenal Ulcer in Chinese Patients (Phase 2)

Duodenal Ulcer

China
Livzon Pharmaceutical Group Inc.

Completed

Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) Booster Study (COVID-19)

COVID-19 Pandemic

Malaysia, Pakistan
Livzon Pharmaceutical Group Inc.

Active, not recruiting

Exploratory Clinical Study to Evaluation of the Safety and Immunogenicity of Bivalent Vaccine V-01D-351 (COVID-19)

COVID-19 Pandemic

China
Livzon Pharmaceutical Group Inc.

Unknown

Shenqi Fuzheng Injection for the Treatment of Cancer-related Fatigue in Patients(BCS) With Digestive Tract .

Carcinogenic Fatigue

China
Livzon Pharmaceutical Group Inc.

Completed

Ilaprazole for the Treatment of Duodenal Ulcer in Chinese Patients

Duodenal Ulcer
Livzon Pharmaceutical Group Inc.

Completed

Ilaprazole for the Treatment of Duodenal Ulcer in Chinese Patients (Phase 3)

Duodenal Ulcer

China
Livzon Pharmaceutical Group Inc.

Recruiting

A Study to Evaluate the Efficacy and Safety of LZM012 (Psoriasis)

Psoriasis

China
Livzon Pharmaceutical Group Inc.

Active, not recruiting

Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) Phase III (COVID-19)

COVID-19 Pandemic

Philippines, Indonesia, Russian Federation
Livzon Pharmaceutical Group Inc.

Active, not recruiting

Immunogenicity and Safety of Sequential Immunization of Recombinant SARS-CoV-2 Fusion Protein Vaccine (COVID-19)

COVID-19 Pandemic

China
Livzon Pharmaceutical Group Inc.

Completed

Ilaprazole for the Treatment and Prevention of Peptic Ulcer Bleeding in Chinese Patients

Peptic Ulcer Hemorrhage
Livzon Pharmaceutical Group Inc.

Completed

IIaprazole for the Treatment and Prevention of Peptic Ulcer Bleeding in Chinese Patients

Peptic Ulcer Hemorrhage
Livzon Pharmaceutical Group Inc.

Completed

Efficacy and Safety of 1-week Triple Therapy With Ilaprazole for the Eradication of Helicobacter Pylori

Helicobacter Pylori Eradication
Livzon Pharmaceutical Group Inc.

Completed

Ilaprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Chinese Patients

Gastroesophageal Reflux Disease
LIVMOR, Inc.
North Texas Veterans Healthcare System; Texas Health Dallas

Completed

The LIVMOR Data Collection Study for the Development and Validation of L-1000AF System

Atrial Fibrillation

United States
Noom Inc.
Arizona Liver Health

Completed

Effects of Online App Weight Loss Programs on Liver Health in Obese Adults

Fatty Liver | Weight Loss | NAFLD | NASH

United States
Livzon Pharmaceutical Group Inc.
Palm Beach CRO; Keystone Bioanalytical, Inc.

Completed

Single-dose Escalation Study of SQ-001 Infusion to Characterize the PK Profiles of Major Sentinel Compounds in Healthy Adult Volunteers in US

Solid Tumor Refractory to Standard Therapy

United States
Foundation for Liver Research
Interscope, Inc.

Completed

EndoRotor® Ablation of Barrett's Esophagus: Safety and Feasibility Study

Barretts Esophagus With Dysplasia

Netherlands
Fatty Liver and Alcoholic Liver Disease Study Group...
Unimed Scientific Inc.

Unknown

A Hepatitis B With Hepatic Steatosis Study (HBHS)

Hepatitis B, Chronic | Hepatic Steatosis

China
Fatty Liver and Alcoholic Liver Disease Study Group...
Unimed Scientific Inc.

Unknown

Fatty Liver Disease Collaborative Research in China (FLDCR)

Fatty Liver | Non-alcoholic Fatty Liver Disease | Fatty Liver, Alcoholic

China
Keith D Lindor, M.D.
Ajinomoto USA, INC.

Completed

Effects of Alanine in Patients With Nonalcoholic Steatohepatitis

Nonalcoholic Steatohepatitis

United States
Drug Induced Liver Disease Study Group
Unimed Scientific Inc.

Completed

A Retrospective Study on Drug Induced Liver Injury in China (DILI-R)

Drug-Induced Liver Injury

China
Mirum Pharmaceuticals, Inc.
Lumena Pharmaceuticals, Inc.; Childhood Liver Disease Research and Education...

Completed

An Extension Study to Evaluate the Long-Term Safety and Durability of Effect of LUM001 in the Treatment of Cholestatic Liver Disease in Pediatric Subjects With Alagille Syndrome (IMAGINE-II)

Alagille Syndrome

United States, Canada
Livzon Pharmaceutical Group Inc.
Fifth Affiliated Hospital, Sun Yat-Sen University

Completed

Efficacy and Safety of Ilaprazole Based Bismuth-containing Quadruple Regimen for the First-line Treatment of Helicobacter Pylori Infection

Helicobacter Pylori Eradication Antibiotic
IND Diagnostic Inc.

Unknown

Evaluation of the IND One Step Strep A Rapid Test vs. Culture

Strep Throat

United States
Mirum Pharmaceuticals, Inc.
Childhood Liver Disease Research and Education Network

Completed

Evaluation of LUM001 in the Reduction of Pruritus in Alagille Syndrome (ITCH)

Alagille Syndrome

United States, Canada
Myanmar Liver Foundation

Recruiting

Stop Hep B @ Birth

Hepatitis B

Myanmar
Egyptian Liver Hospital

Completed

Clinical Impacts of Achieving SVR in Patients With Advanced Hepatic Fibrosis Related to Chronic HCV Treated With Direct Acting Antivirals

HCC in Chronic HCV Patients With Advanced Liver Fibrosis
Egyptian Liver Hospital

Completed

ELRIAH Score: A Simple Score for HCC Risk Stratification in CHC Patients With Cirrhosis or Advanced Liver Fibrosis Who Achieved SVR Following DAA Therapy

HCC
Egyptian Liver Hospital

Completed

Model Towards Elimination of Hepatitis C Infection in Egypt: Feasibility and Effectiveness in 73 Villages

Hepatitis C, Chronic
Fatty liver Foundation

Completed

A Self Selected Population Study of Undiagnosed NAFLD and NASH, Using an Echosens FibroScan, in at Risk Populations (SUNN)

Fatty Liver | NAFLD | NASH - Nonalcoholic Steatohepatitis | Cirrhosis, Liver

United States
Egyptian Liver Hospital

Unknown

Safety & Efficacy of Sofosbuvir 400mg/Ledipasvir 90mg in the Treatment of Chronic Hepatitis C Adolescents

Hepatitis C Virus Infection, Response to Therapy of

Egypt
Liver Institute PLLC

Not yet recruiting

Screening, Treatment, and Eradication of Hep C

Hepatitis C Virus Infection
Egyptian Liver Hospital

Active, not recruiting

The Study of the Validation of General Evaluation Score (GES) in the Prediction of Hepatocellular Carcinoma Risk Among Patients With Advanced Fibrosis and Cirrhosis Who Achieved Sustained Virological Response for Hepatitis C Virus After Direct Acting Antiviral Drugs

Hepatocellular Carcinoma

Egypt
The Third Xiangya Hospital of Central South University
Livzon Pharmaceutical Group Inc.; Yung Shin Pharm. Ind. Co., Ltd.

Completed

The Efficacy and Safety of Ilaprazole/Doxycycline-based Bismuth-containing Quadruple Therapy on Hp Infected Duodenal Ulcers

Duodenal Ulcer Due to Helicobacter Pylori

China
National Liver Institute, Egypt

Completed

Role of Oral Zinc in Reducing Neonatal Indirect Hyperbilirubinemia

Neonatal Jaundice

Egypt
National Liver Institute, Egypt

Unknown

Gastrostomy-Biliary Diversion: Innovative Management for Bile Canalicular Transport Disorders

Progressive Familial Intrahepatic Cholestasis

Egypt
National Liver Institute, Egypt

Completed

Eight Weeks Sofosbovir/Ledipasvir in HCV Infected Children Aged 4 to 10 Years

Hepatitis C, Chronic | Children, Only

Egypt
Foundation for Liver Research

Completed

Lowering Viral Load With Nucleos(T)Ide Analogues Prior to Peginterferon Treatment to Ncrease Sustained Response in CHB (PEGON)

Chronic Hepatitis B

Netherlands, China
Foundation for Liver Research

Completed

Effect of ASV and DCV Therapy on the Quality of Immune Status in Chronic HCV Patients (ImmunoDual)

Chronic Hepatitis C

Netherlands
Foundation for Liver Research

Completed

Genetic Study of Peginterferon Treatment in Hepatitis B Patients: The GIANT-B Study (GIANT-B)

Chronic Hepatitis B

Netherlands
Foundation for Liver Research

Withdrawn

Pancreatic Enzyme Suppletion in Pancreatic Cancer (EPC)

Adenocarcinoma of the Pancreas | Normal Pancreatic Exocrine Function

Netherlands

3

Subscribe